A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer | Zendy

Christine BrezdenMasley | Zendy; Kelly E. Fathers | Zendy; Megan Coombes | Zendy; Behin Pourmirza | Zendy; Cloris Xue | Zendy; Katarzyna J. Jerzak | Zendy

Open Access

A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer

Author(s) -

Christine BrezdenMasley,

Kelly E. Fathers,

Megan Coombes,

Behin Pourmirza,

Cloris Xue,

Katarzyna J. Jerzak

Publication year - 2020

Publication title -

breast cancer research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.908

H-Index - 154

eISSN - 1573-7217

pISSN - 0167-6806

DOI - 10.1007/s10549-020-05960-4

Subject(s) - medicine , breast cancer , lumpectomy , population , cancer , cohort , stage (stratigraphy) , cancer registry , health care , oncology , gynecology , mastectomy , environmental health , biology , paleontology , economics , economic growth

To update and expand on data related to treatment, resource utilization, and costs by cancer stage in Canadian patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer (BC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research